Tina Abild Olesen

Tina Abild Olesen has held various high-level positions in the pharmaceutical industry, specifically within the diabetes franchise. With a background in economics and business administration from Copenhagen Business School, Tina has also served as a board member in the healthcare sector. Tina Abild brings a wealth of experience in commercial strategy, marketing, and corporate affairs to their current roles at Novo Nordisk and Embla Medical.